Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
复制标题

DOI:
10.1021/acsnano.7b05108
复制
发表时间:
2018-01-23
期刊:
影响因子:
17.1
通讯作者:
Grodzinski P
Grodzinski P
中科院分区:
材料科学1区
文献类型:
--
作者:
Hartshorn CM;Bradbury MS;Lanza GM;Nel AE;Rao J;Wang AZ;Wiesner UB;Yang L;Grodzinski P

文献摘要

参考文献

被引文献

相似文献

正在进行的纳米技术在癌症治疗和诊断中的应用研究已经证明了其在当代肿瘤学中的优势以及其内在的局限性。自 2005 年以来,美国国家癌症研究所每 5 年发布一次癌症纳米技术计划。最近的迭代有助于整理该领域正在进行的基础和转化工作,并展示了其在几个不断发展的领域的广度。仅从技术角度来看,该领域已经取得了巨大的发展和成功。然而,相对于纳米级材料在当代肿瘤学中的应用,对人类癌症生物学的理解仍然不完全。因此,本综述介绍了癌症纳米技术的几个不断发展的领域,以确定需要解决的关键临床和生物学挑战,以改善患者的治疗结果。从这个临床角度出发,讨论了一些纳米解决方案,试图克服传统治疗和诊断在临床环境中面临的障碍。最后,讨论了未来的战略展望,以强调对下一代癌症纳米技术工具的需求,这些工具旨在解决临床癌症护理中的关键差距。
Ongoing research into the application of nanotechnology for cancer treatment and diagnosis has demonstrated its advantages within contemporary oncology as well as its intrinsic limitations. The National Cancer Institute publishes the Cancer Nanotechnology Plan every 5 years since 2005. The most recent iteration helped codify the ongoing basic and translational efforts of the field and displayed its breadth with several evolving areas. From merely a technological perspective, this field has seen tremendous growth and success. However, an incomplete understanding of human cancer biology persists relative to the application of nanoscale materials within contemporary oncology. As such, this review presents several evolving areas in cancer nanotechnology in order to identify key clinical and biological challenges that need to be addressed to improve patient outcomes. From this clinical perspective, a sampling of the nano-enabled solutions attempting to overcome barriers faced by traditional therapeutics and diagnostics in the clinical setting, are discussed. Finally, a strategic outlook of the future is discussed to highlight the need for next-generation cancer nanotechnology tools designed to address critical gaps in clinical cancer care.
DOI: 10.1016/j.addr.2016.09.006
发表时间: 2017-04
影响因子: 16.1
作者:
Atukorale PU;Covarrubias G;Bauer L;Karathanasis E
通讯作者: Karathanasis E
DOI: 10.1158/0008-5472.can-07-6849
发表时间: 2008-08-01
期刊: Cancer research
影响因子: 11.2
作者:
Barkan D;Kleinman H;Simmons JL;Asmussen H;Kamaraju AK;Hoenorhoff MJ;Liu ZY;Costes SV;Cho EH;Lockett S;Khanna C;Chambers AF;Green JE
通讯作者: Green JE
临床翻译的二氧化硅纳米颗粒作为以癌为标志性的探针进行图像引导的手术和干预措施。
DOI: 10.1039/c2ib20174g
发表时间: 2013-01
期刊: Integrative biology : quantitative biosciences from nano to macro
影响因子: --
作者:
Bradbury MS;Phillips E;Montero PH;Cheal SM;Stambuk H;Durack JC;Sofocleous CT;Meester RJ;Wiesner U;Patel S
通讯作者: Patel S
DOI: 10.1021/nl803405h
发表时间: 2009-01
期刊: Nano letters
影响因子: 10.8
作者:
Burns AA;Vider J;Ow H;Herz E;Penate-Medina O;Baumgart M;Larson SM;Wiesner U;Bradbury M
通讯作者: Bradbury M
DOI: 10.1073/pnas.1214547110
发表时间: 2013-04-23
影响因子: 11.1
作者:
Arvizo, Rochelle R.;Saha, Sounik;Mukherjee, Priyabrata
通讯作者: Mukherjee, Priyabrata